1. Home
  2. CTSO vs HYPR Comparison

CTSO vs HYPR Comparison

Compare CTSO & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

N/A

Current Price

$0.77

Market Cap

45.7M

Sector

Health Care

ML Signal

N/A

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

N/A

Current Price

$1.17

Market Cap

107.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CTSO
HYPR
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.7M
107.9M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
CTSO
HYPR
Price
$0.77
$1.17
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$5.38
$1.28
AVG Volume (30 Days)
67.1K
291.7K
Earning Date
01-01-0001
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
9.68
EPS
N/A
N/A
Revenue
$22,503,908.00
$12,890,000.00
Revenue This Year
$7.29
$5.96
Revenue Next Year
$8.91
$34.43
P/E Ratio
N/A
N/A
Revenue Growth
48.53
16.84
52 Week Low
$0.60
$0.53
52 Week High
$1.39
$2.22

Technical Indicators

Market Signals
Indicator
CTSO
HYPR
Relative Strength Index (RSI) 54.78 55.14
Support Level $0.62 $1.04
Resistance Level $0.84 $1.19
Average True Range (ATR) 0.04 0.07
MACD 0.01 0.01
Stochastic Oscillator 59.46 68.29

Price Performance

Historical Comparison
CTSO
HYPR

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Share on Social Networks: